Gruft, James

Gruft, James was paid $14K by Medicaid between Jan 2018 and Nov 2024, across 6 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 88% of everything it billed.

33Billing provider infoGRUFT, JAMES
OAKBROOK TERRACE, IL 60181

33aNPI1417173865assigned 04/17/2007

33bProvider typePain Medicine Physician

28Total paid$14K

24GClaims3,311

24DCodes billed6

24AFirst – last monthJan 2018 – Nov 2024

Compared with peers

Next to other Pain Medicine Physician providers in Illinois

Rank by total paid#6 of 14

Median peer was paid$9K

This provider vs. median1.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	253	$2K
2019	592	$2K
2020	612	$909.30
2021	369	$2K
2022	439	$3K
2023	352	$1K
2024incomplete	694	$3K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	88%	2,252	1,842	$13K
96127		5.5%	653	511	$787.84
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	4.3%	151	134	$608.77
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	1.0%	136	100	$149.27
99490	Ccm add 20min	<1%	53	40	$142.08
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	0%	66	53	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.